Reference:EU EMA/786433/2022 Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 2.9: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 4: | Line 4: | ||
|RefDocPart=2.9 | |RefDocPart=2.9 | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00083-Enr-enr ++ TAG-00029-Inf-rte ++ TAG-00082-Scr-hlu ++ TAG-00281-Und-sse | ||
| | |RefModule=3 | ||
| | |RefUnit=3.2.1 | ||
}} | }} | ||
| Line 14: | Line 14: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 3 — Unit 3.2.1 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 30: | Line 33: | ||
| | | | ||
|- | |- | ||
! Tags | ! Tags | ||
| | | [[Glossary:TAG-00083-Enr-enr|Enrolment]], [[Glossary:TAG-00029-Inf-rte|Informed consent]], [[Glossary:TAG-00082-Scr-hlu|Screening]], [[Glossary:TAG-00281-Und-sse|Undue inducement]] | ||
|- | |||
| | |||
|- | |||
| | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | EU EMA/786433/2022
Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 |
| Validity area | EU |
| Scope(s) | G |
| Document name | EMA/786433/2022
Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units |
| Version / Revision | 15-Nov-2022 |
| Status | Current |
| Document type | Official guideline |
| Language(s) | EN |
| Description | EMA/786433/2022
Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 3 — Unit 3.2.1 |
| Scope | G |
| Document part | 2.9 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Enrolment, Informed consent, Screening, Undue inducement |
| Comment | Recruitment and consent: key considerations |
Content
2.9. Recruitment and consent Points to consider: • Recruitment strategies. • Volunteer database. • Collection and verification of the trial participants medical history. • Contact with the trial participant’s primary physician/family doctor. • Procedures to prevent ‘over-volunteering’. • Routine screening procedure (including any counselling or procedures for handling reportable diseases e.g. for positive serology results). • Trial participant records. • Procedures taken to verify the identity of the trial participants. Procedures for payment. • Procedures for taking consent (including verification that trial participants have understood the information).
